Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1261 to 1264 of 1264 entries
Sorted by: Best Match Show Resources per page
Glioblastoma Contains Topologically Distinct Proliferative and Metabolically Defined Subpopulations of Nestin- and Glut1-Expressing Cells.

Journal of neuropathology and experimental neurology

Prosniak M, Kenyon LC, Hooper DC.
PMID: 34297838
J Neuropathol Exp Neurol. 2021 Aug 11;80(7):674-684. doi: 10.1093/jnen/nlab044.

The difficulty in treatment of glioblastoma is a consequence of its natural infiltrative growth and the existence of a population of therapy-resistant glioma cells that contribute to growth and recurrence. To identify cells more likely to have these properties,...

Cite
Prosniak M, Kenyon LC, Hooper DC. Glioblastoma Contains Topologically Distinct Proliferative and Metabolically Defined Subpopulations of Nestin- and Glut1-Expressing Cells. J Neuropathol Exp Neurol. 2021;80(7):674-684doi: 10.1093/jnen/nlab044.
Prosniak, M., Kenyon, L. C., & Hooper, D. C. (2021). Glioblastoma Contains Topologically Distinct Proliferative and Metabolically Defined Subpopulations of Nestin- and Glut1-Expressing Cells. Journal of neuropathology and experimental neurology, 80(7), 674-684. https://doi.org/10.1093/jnen/nlab044
Prosniak, Michael, et al. "Glioblastoma Contains Topologically Distinct Proliferative and Metabolically Defined Subpopulations of Nestin- and Glut1-Expressing Cells." Journal of neuropathology and experimental neurology vol. 80,7 (2021): 674-684. doi: https://doi.org/10.1093/jnen/nlab044
Prosniak M, Kenyon LC, Hooper DC. Glioblastoma Contains Topologically Distinct Proliferative and Metabolically Defined Subpopulations of Nestin- and Glut1-Expressing Cells. J Neuropathol Exp Neurol. 2021 Aug 11;80(7):674-684. doi: 10.1093/jnen/nlab044. PMID: 34297838.
Copy Download .nbib Format: NLM
Impact of Primary Hemostasis Disorders on Late Major Bleeding Events among Anticoagulated Atrial Fibrillation Patients Treated by TAVR.

Journal of clinical medicine

Dietrich L, Kibler M, Matsushita K, Marchandot B, Trimaille A, Reydel A, Diop B, Truong PD, Trung AM, Trinh A, Carmona A, Hess S, Jesel L, Ohlmann P, Morel O.
PMID: 35011952
J Clin Med. 2021 Dec 31;11(1). doi: 10.3390/jcm11010212.

BACKGROUND: Bleeding events are among the striking complications following transcatheter aortic valve replacement (TAVR), and bleeding prediction models are crucially warranted. Several studies have highlighted that primary hemostasis disorders secondary to persistent loss of high-molecular-weight (HMW) multimers of the...

Cite
Dietrich L, Kibler M, Matsushita K, et al. Impact of Primary Hemostasis Disorders on Late Major Bleeding Events among Anticoagulated Atrial Fibrillation Patients Treated by TAVR. J Clin Med. 2021;11(1)doi: 10.3390/jcm11010212.
Dietrich, L., Kibler, M., Matsushita, K., Marchandot, B., Trimaille, A., Reydel, A., Diop, B., Truong, P. D., Trung, A. M., Trinh, A., Carmona, A., Hess, S., Jesel, L., Ohlmann, P., & Morel, O. (2021). Impact of Primary Hemostasis Disorders on Late Major Bleeding Events among Anticoagulated Atrial Fibrillation Patients Treated by TAVR. Journal of clinical medicine, 11(1), . https://doi.org/10.3390/jcm11010212
Dietrich, Laurent, et al. "Impact of Primary Hemostasis Disorders on Late Major Bleeding Events among Anticoagulated Atrial Fibrillation Patients Treated by TAVR." Journal of clinical medicine vol. 11,1 (2021). doi: https://doi.org/10.3390/jcm11010212
Dietrich L, Kibler M, Matsushita K, Marchandot B, Trimaille A, Reydel A, Diop B, Truong PD, Trung AM, Trinh A, Carmona A, Hess S, Jesel L, Ohlmann P, Morel O. Impact of Primary Hemostasis Disorders on Late Major Bleeding Events among Anticoagulated Atrial Fibrillation Patients Treated by TAVR. J Clin Med. 2021 Dec 31;11(1). doi: 10.3390/jcm11010212. PMID: 35011952; PMCID: PMC8746148.
Copy Download .nbib Format: NLM
Coagulation profile of human COVID-19 convalescent plasma.

Scientific reports

Klompas AM, van Helmond N, Juskewitch JE, Pruthi RK, Sexton MA, Soto JCD, Klassen SA, Senese KA, van Buskirk CM, Winters JL, Stubbs JR, Hammel SA, Joyner MJ, Senefeld JW.
PMID: 35022488
Sci Rep. 2022 Jan 12;12(1):637. doi: 10.1038/s41598-021-04670-1.

Convalescent plasma is used to treat COVID-19. There are theoretical concerns about the impact of pro-coagulant factors in convalescent plasma on the coagulation cascade particularly among patients with severe COVID-19. The aim of this study was to evaluate the...

Cite
Klompas AM, van Helmond N, Juskewitch JE, et al. Coagulation profile of human COVID-19 convalescent plasma. Sci Rep. 2022;12(1):637doi: 10.1038/s41598-021-04670-1.
Klompas, A. M., van Helmond, N., Juskewitch, J. E., Pruthi, R. K., Sexton, M. A., Soto, J. C. D., Klassen, S. A., Senese, K. A., van Buskirk, C. M., Winters, J. L., Stubbs, J. R., Hammel, S. A., Joyner, M. J., & Senefeld, J. W. (2022). Coagulation profile of human COVID-19 convalescent plasma. Scientific reports, 12(1), 637. https://doi.org/10.1038/s41598-021-04670-1
Klompas, Allan M, et al. "Coagulation profile of human COVID-19 convalescent plasma." Scientific reports vol. 12,1 (2022): 637. doi: https://doi.org/10.1038/s41598-021-04670-1
Klompas AM, van Helmond N, Juskewitch JE, Pruthi RK, Sexton MA, Soto JCD, Klassen SA, Senese KA, van Buskirk CM, Winters JL, Stubbs JR, Hammel SA, Joyner MJ, Senefeld JW. Coagulation profile of human COVID-19 convalescent plasma. Sci Rep. 2022 Jan 12;12(1):637. doi: 10.1038/s41598-021-04670-1. PMID: 35022488; PMCID: PMC8755772.
Copy Download .nbib Format: NLM
Influences of advanced glycosylation end products on the inner blood-retinal barrier in a co-culture cell model .

Open life sciences

Yuan C, Mo Y, Yang J, Zhang M, Xie X.
PMID: 33817250
Open Life Sci. 2020 Aug 24;15(1):619-628. doi: 10.1515/biol-2020-0067. eCollection 2020.

Advanced glycosylation end products (AGEs) are harmful factors that can damage the inner blood-retinal barrier (iBRB). Rat retinal microvascular endothelial cells (RMECs) were isolated and cultured, and identified by anti-CD31 and von Willebrand factor polyclonal antibodies. Similarly, rat retinal...

Cite
Yuan C, Mo Y, Yang J, et al. Influences of advanced glycosylation end products on the inner blood-retinal barrier in a co-culture cell model . Open Life Sci. 2020;15(1):619-628doi: 10.1515/biol-2020-0067.
Yuan, C., Mo, Y., Yang, J., Zhang, M., & Xie, X. (2020). Influences of advanced glycosylation end products on the inner blood-retinal barrier in a co-culture cell model . Open life sciences, 15(1), 619-628. https://doi.org/10.1515/biol-2020-0067
Yuan, Chen, et al. "Influences of advanced glycosylation end products on the inner blood-retinal barrier in a co-culture cell model ." Open life sciences vol. 15,1 (2020): 619-628. doi: https://doi.org/10.1515/biol-2020-0067
Yuan C, Mo Y, Yang J, Zhang M, Xie X. Influences of advanced glycosylation end products on the inner blood-retinal barrier in a co-culture cell model . Open Life Sci. 2020 Aug 24;15(1):619-628. doi: 10.1515/biol-2020-0067. eCollection 2020. PMID: 33817250; PMCID: PMC7747502.
Copy Download .nbib Format: NLM
Showing 1261 to 1264 of 1264 entries